September 2018

Editorial 
Biomarkers for Lassa fever outcome?
Kyle Rosenke, David Safronetz, Heinz Feldmann
Annals of Infection  
2018,  
2:
4  
Editorial 
Second-line antiretroviral therapy in resource-limited settings: what we know and the challenges of ever-changing antiretroviral therapy
Diganth Ningappa, Ann C. Collier
Annals of Infection  
2018,  
2:
3